Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
SPORE in Prostate Cancer
Explore this Website
I am interested in...
Wayfinder menu
VIVO
Research Home
Departments
Home
About Us
Toggle About Us menu options
Affiliations
Donate
Resources
Job Opportunities
Contact Us
Research
Toggle Research menu options
Project 1
Project 2
Project 3
Project 4
Programs
Toggle Programs menu options
Career Enhancement Program
Toggle Career Enhancement Program menu options
2023 CEP Projects
Developmental Research Program
Toggle Developmental Research Program menu options
2023 DRP Awardee Projects
Cores
Toggle Cores menu options
Administrative Core
Biospecimen & Pathology
Computational Biology - Biostatistics
Investigators
Publications
News
Weill Cornell Medicine
Care
Discover
Teach
Home
About Us
Research
Programs
Cores
Investigators
Publications
News
Home
Publications
Publications
Found 10 results
Author
Title
Type
Year
Filters:
Author
is
Demichelis, Francesca
[Clear All Filters]
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
C
Beltran H
,
Nanus DM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
,
Tagawa ST
,
Demichelis F
,
Romanel A
,
Conteduca V
,
Casiraghi N
et al.
. 2020.
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
.
J Clin Invest. 130(4):1653-1668.
I
Sailer V
,
Eng KWa
,
Zhang T
,
Bareja R
,
Pisapia DJ
,
Sigaras A
,
Bhinder B
,
Romanel A
,
Wilkes D
,
Sticca E
et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
Liu D
,
Barbieri CE
,
Rubin MA
,
Demichelis F
,
Mosquera JMiguel
,
Elemento O
,
Sboner A
,
Shoag JE
,
Poliak D
,
Goueli RS
et al.
. 2020.
Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes.
.
Nat Commun. 11(1):1987.
N
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
P
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
Beltran H
,
Oromendia C
,
Danila DC
,
Montgomery B
,
Hoimes C
,
Szmulewitz RZ
,
Vaishampayan U
,
Armstrong AJ
,
Stein M
,
Pinski J
et al.
. 2018.
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers.
.
Clin Cancer Res.
R
Rubin MA
,
Beltran H
,
Ballman KV
,
Sboner A
,
Cyrta J
,
Demichelis F
,
Augspach A
,
De Filippo MRosaria
,
Prandi D
,
Thienger P
et al.
. 2020.
Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity.
.
Nat Commun. 11(1):5549.
T
Beltran H
,
Demichelis F
. 2021.
Therapy considerations in neuroendocrine prostate cancer: what next?
Endocr Relat Cancer. 28(8):T67-T78.
Locallo A
,
Prandi D
,
Fedrizzi T
,
Demichelis F
. 2019.
TPES: tumor purity estimation from SNVs.
.
Bioinformatics. 35(21):4433-4435.
Liu D
,
Augello MA
,
Grbesa I
,
Prandi D
,
Liu Y
,
Shoag JE
,
R Karnes J
,
Trock BJ
,
Klein EA
,
Den RB
et al.
. 2021.
Tumor subtype defines distinct pathways of molecular and clinical progression in primary prostate cancer.
.
J Clin Invest. 131(10)